Feb 24 (Reuters) - Theranos founder Elizabeth Holmes' 2022 conviction on charges of misleading investors in her blood testing startup was upheld by a U.S. appeals court in San Francisco on Monday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.